Companies › NDRA
ENDRA LIFE SCIENCES INC (NDRA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001681682 · EDGAR filings · Updated 2026-07-22
ENDRA LIFE SCIENCES INC (NDRA) has reported institutional ownership of 7.2%, with 8 institutional managers holding positions valued at $416.8K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — 425 filed
- 2026-07-17 — 425 filed
- 2026-07-09 — Current report (8-K) filed
- 2026-06-29 — SCHEDULE 13D/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ENDRA LIFE SCIENCES INC has 8 institutional holders and institutional ownership of 7.2%.
Insider activity
Insiders reported 11 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
XENETIC BIOSCIENCES INC (XBIO) · PROCESSA PHARMACEUTICALS INC (PCSA) · Pulmatrix Inc (PULM) · POLYRIZON LTD (PLRZ) · Scienture Holdings Inc (SCNX) · Lunai Bioworks Inc (LNAI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.